Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2003
02/20/2003US20030036505 Signal transduction pathway component polynucleotides, polypeptides, antibodies and methods based thereon
02/20/2003US20030036504 Modululation of both fasting and postprandial lipid levels.
02/20/2003US20030036502 Methods for enhancing wound healing
02/20/2003US20030036501 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
02/20/2003US20030036500 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
02/20/2003US20030036193 Inducing the migration of progenitor cells into regions of nervous tissue damage; identify region of nervous tissue damage, incubate with progenitor cells and transforming growth factor, monitor therapeutic response
02/20/2003US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides
02/20/2003US20030036181 Peptide extended glycosylated polypeptides
02/20/2003US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders
02/20/2003US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036174 Hair follicle growth factor proteins
02/20/2003US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases
02/20/2003US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
02/20/2003US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
02/20/2003US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor
02/20/2003US20030036163 Novel PN9826 nucleic acids and use thereof
02/20/2003US20030036119 Nucleotide sequences coding polypeptides for use in the treatment, diagnosis and prevention of cell proliferative disorders
02/20/2003US20030036114 Nucleotide sequences coding polyopeptide for use in the diagnosis and treatment of cell proliferative disorders
02/20/2003US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders
02/20/2003US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins
02/20/2003US20030036102 Cathepsin differentially expressed in lung cancer
02/20/2003US20030036101 Use of neuregulin-beta as an indicator and/or target
02/20/2003US20030036094 Nucleotide sequences coding polypeptide for use in the treatment of kidney, skin and cancer disorders
02/20/2003US20030036074 Novel nucleic acid sequences encoding human transporters, a human atpase molecule, a human ubiquitin hydrolase-like molecule, a human ubiquitin conjugating enzyme-like molecule, and uses therefor
02/20/2003US20030036061 Nucloetide sequences coding polypeptide for use in the treatment and diagnosis of infections,cancer, skin, cardiovascular and gastrointestinal disorders
02/20/2003US20030036060 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/20/2003US20030036056 Inhibitors and target molecule co-localization
02/20/2003US20030035845 Composition for sustained release of non-aggregated erythropoietin
02/20/2003US20030035831 Pharmaceutical compositions for buccal delivery of pain relief medications
02/20/2003US20030035820 Crosslinked keratin; thin film; wound healing agents, tissues, diffusion membranes
02/20/2003US20030035819 Skin care composition that mediates cell to cell communication
02/20/2003US20030035816 Soluble ctla4 mutant molecules and uses thereof
02/20/2003US20030035815 Recombitope peptides
02/20/2003US20030035808 Complexing heat shock proteins; anticancer agents
02/20/2003US20030035807 Self antigen vaccines for treating B cell lymphomas and other cancers
02/20/2003US20030035804 In situ drug delivery
02/20/2003US20030035801 Stimulating neutrophil function to treat inflammatory bowel disease
02/20/2003US20030035800 Glycosylated humanized B-cell specific antibodies
02/20/2003US20030035799 Glycosylated antibody
02/20/2003US20030035793 Novel immune response targeting molecules
02/20/2003US20030035790 Anticancer agents, antinflamamtory agents, infection therapy
02/20/2003US20030035789 Purging lymphocytes
02/20/2003US20030035788 Method for use of IGF-binding protein for selective sensitization of target cells in vivo
02/20/2003US20030035786 Crosslinked gelation; wound healinbg agents
02/20/2003US20030035780 Controlling bone metabolism; remodeling
02/20/2003US20030035778 Methods and compositions for the dry powder formulation of interferon
02/20/2003US20030035775 Inhalation administering; mixture of drug and solvent
02/20/2003US20030035774 Salt/ion pair medicinal aerosol formulation
02/20/2003CA2467922A1 Modulation of angiogenesis by a-beta peptides
02/20/2003CA2467919A1 Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
02/20/2003CA2462200A1 Peptidomimetics of biologically active metallopeptides
02/20/2003CA2459071A1 Use of inhibitors of heparin-binding epidermal growth factor or inhibitors of its receptors for the preparation of drugs useful for treating myeloma
02/20/2003CA2457694A1 Platelet-derived growth factor protection of cardiac myocardium
02/20/2003CA2457624A1 Nutrient therapy for immuno-compromised patients
02/20/2003CA2457424A1 Molecular interactions in cells
02/20/2003CA2457400A1 Modulation of leukocyte-endothelial interactions following ischemia
02/20/2003CA2457322A1 Process for the maturation of dentritic cells and a vaccine
02/20/2003CA2456964A1 Melanin-concentrating hormone antagonists
02/20/2003CA2456928A1 Cellular virus receptors and methods of use
02/20/2003CA2456909A1 Methods for the treatment and prognosis of leukemia and other cancer types
02/20/2003CA2456881A1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
02/20/2003CA2456857A1 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof
02/20/2003CA2456762A1 Interleukin-1 receptors in the treatment of diseases
02/20/2003CA2456761A1 Novel depsipeptides and process for preparing same
02/20/2003CA2456708A1 Crystal forms and mutants of rank ligand
02/20/2003CA2456607A1 Uses of mammalian cytokine; related reagents
02/20/2003CA2456571A1 Human secreted proteins, their encoding polynucleotides, and uses thereof
02/20/2003CA2456549A1 The treatment of lipodystrophy
02/20/2003CA2456369A1 Proteins associated with cell growth, differentiation, and death
02/20/2003CA2456295A1 Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation
02/20/2003CA2456247A1 Use of il-18 inhibitors in hypersensitivity disorders
02/20/2003CA2456223A1 Regulation of the apj receptor for use in the treatment or prophylaxis of cardiac diseases
02/20/2003CA2455756A1 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
02/20/2003CA2455498A1 Antisense modulation of apolipoprotein(a) expression
02/20/2003CA2455336A1 Peptides that bind to atherosclerotic lesions
02/20/2003CA2455027A1 In vitro assays for inhibitors of hiv capsid conformational changes and for hiv capsid formation
02/20/2003CA2454768A1 Molecule
02/20/2003CA2454648A1 Irinotecan for treatment of cancer
02/20/2003CA2454643A1 Methods for the treatment of cancer with irinotecan based on cyp3a5
02/20/2003CA2454640A1 Methods for treatment of cancer using irinotecan based on ugt1a1
02/20/2003CA2454637A1 Use of irinotecan for improved treatment of cancer based on mdr1
02/20/2003CA2454627A1 Methods for improved treatment of cancer with irinotecan based on mrp1
02/20/2003CA2454519A1 Hprp4s as modifiers of the p53 pathway and methods of use
02/20/2003CA2454514A1 Sphks as modifiers of the p53 pathway and methods of use
02/20/2003CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists
02/20/2003CA2454251A1 Isolation and mobilization of stem cells expressing vegfr-1
02/20/2003CA2453995A1 Tacis and br3 polypeptides and uses thereof
02/20/2003CA2453433A1 Methods of use for novel sulfur containing organic nitrate compounds
02/20/2003CA2453248A1 Compositions and methods for the therapy and diagnosis of breast cancer
02/20/2003CA2453245A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates
02/20/2003CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
02/19/2003WO2004015060A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
02/19/2003WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
02/19/2003EP1284423A2 Adrenic acid (delta 7,10,13,16 docosatetraenoic acid ) receptor and uses thereof
02/19/2003EP1284298A2 Identification and use of molecules implicated in pain
02/19/2003EP1284297A2 Identification and use of molecules implicated in pain
02/19/2003EP1284292A2 Human B-cell Translocation Gene-3
02/19/2003EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA
02/19/2003EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby
02/19/2003EP1284143A1 A process for the preparation of pharmaceutical formulations containing lactoferrin description
1 ... 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 1917 1918 1919 1920 1921 1922 ... 3163